Tumor Necrosis Factor-α in Heart Failure: an Updated Review

[1]  Seungtae Kim,et al.  Sustained stimulation of β2- and β3-adrenergic receptors leads to persistent functional pain and neuroinflammation , 2018, Brain, Behavior, and Immunity.

[2]  N. Dhalla,et al.  Role of cytokines and inflammation in heart function during health and disease , 2018, Heart Failure Reviews.

[3]  K. Turksen.  Autophagy in Health and Disease , 2018, Stem Cell Biology and Regenerative Medicine.

[4]  S. N. Naga Prasad,et al.  Proinflammatory Cytokines Mediate GPCR Dysfunction. , 2017, Journal of cardiovascular pharmacology.

[5]  R. Penn,et al.  Bronchoprotection and bronchorelaxation in asthma: New targets, and new ways to target the old ones. , 2016, Pharmacology & therapeutics.

[6]  S. Prabhu,et al.  The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. , 2016, Circulation research.

[7]  George D. Kalliolias,et al.  TNF biology, pathogenic mechanisms and emerging therapeutic strategies , 2016, Nature Reviews Rheumatology.

[8]  Tak W. Mak,et al.  Regulation of tumour necrosis factor signalling: live or let die , 2015, Nature Reviews Immunology.

[9]  T. Ueland,et al.  Inflammatory cytokines as biomarkers in heart failure. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[10]  D. Mann.  Innate immunity and the failing heart: the cytokine hypothesis revisited. , 2015, Circulation research.

[11]  W. Koch,et al.  Temporal and gefitinib-sensitive regulation of cardiac cytokine expression via chronic β-adrenergic receptor stimulation. , 2015, American journal of physiology. Heart and circulatory physiology.

[12]  R. Isseroff,et al.  Catecholamine stress alters neutrophil trafficking and impairs wound healing by β2 adrenergic receptor mediated upregulation of IL-6 , 2013, The Journal of investigative dermatology.

[13]  David C. Young,et al.  G&bgr;&ggr;-Independent Recruitment of G-Protein Coupled Receptor Kinase 2 Drives Tumor Necrosis Factor &agr;–Induced Cardiac &bgr;-Adrenergic Receptor Dysfunction , 2013, Circulation.

[14]  D. Mann,et al.  Positioning of Inflammatory Biomarkers in the Heart Failure Landscape , 2013, Journal of Cardiovascular Translational Research.

[15]  Vijay G Divakaran,et al.  Tumor Necrosis Factor Receptor–Associated Factor 2 Signaling Provokes Adverse Cardiac Remodeling in the Adult Mammalian Heart , 2013, Circulation. Heart failure.

[16]  M. Czech,et al.  β3-Adrenergic Receptor Stimulation Induces E-Selectin-mediated Adipose Tissue Inflammation* , 2012, The Journal of Biological Chemistry.

[17]  H. Anders,et al.  Quantitative Expression of C-Type Lectin Receptors in Humans and Mice , 2012, International journal of molecular sciences.

[18]  Lucía Cabal-Hierro,et al.  Signal transduction by tumor necrosis factor receptors. , 2012, Cellular signalling.

[19]  T. Ueland,et al.  Inflammatory Cytokines in Heart Failure: Mediators and Markers , 2012, Cardiology.

[20]  Shao-Cong Sun.  The noncanonical NF‐κB pathway , 2012, Immunological reviews.

[21]  B. De Paepe,et al.  The Tumor Necrosis Factor Superfamily of Cytokines in the Inflammatory Myopathies: Potential Targets for Therapy , 2011, Clinical & developmental immunology.

[22]  N. Voelkel,et al.  The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse , 2011, Proceedings of the National Academy of Sciences.

[23]  S. Goswami,et al.  Regulation of β-adrenergic receptor function , 2011, Cell cycle.

[24]  B. Chandrasekar,et al.  Tumor necrosis factor receptor 2 signaling limits β-adrenergic receptor-mediated cardiac hypertrophy in vivo , 2011, Basic Research in Cardiology.

[25]  L. Kirshenbaum,et al.  Multiple facets of NF-κB in the heart: to be or not to NF-κB. , 2011, Circulation Research.

[26]  D. Mann.  The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls. , 2011, Circulation research.

[27]  T. Noda,et al.  Inflammasome Activation of Cardiac Fibroblasts Is Essential for Myocardial Ischemia/Reperfusion Injury , 2011, Circulation.

[28]  G. Valen.  Innate immunity and remodelling , 2010, Heart Failure Reviews.

[29]  R. Gottlieb,et al.  Autophagy in health and disease. 5. Mitophagy as a way of life. , 2010, American journal of physiology. Cell physiology.

[30]  C. Murga,et al.  G Protein–Coupled Receptor Kinase 2 Plays a Relevant Role in Insulin Resistance and Obesity , 2010, Diabetes.

[31]  Y. Zhong,et al.  Low responder T cell susceptibility to the suppressive function of regulatory T cells in patients with dilated cardiomyopathy , 2010, Heart.

[32]  W. Emons,et al.  Health-related quality of life is related to cytokine levels at 12 months in patients with chronic heart failure , 2010, Brain, Behavior, and Immunity.

[33]  G. Pasterkamp,et al.  Endogenous Inflammatory Molecules Engage Toll-Like Receptors in Cardiovascular Disease , 2010, Journal of Innate Immunity.

[34]  T. Lawrence,et al.  The resolution of inflammation: anti-inflammatory roles for NF-kappaB. , 2010, The international journal of biochemistry & cell biology.

[35]  V. Brusasco,et al.  Beta-Adrenergic Agonists , 2010, Pharmaceuticals.

[36]  Eva Szomolanyi-Tsuda,et al.  The AIM2 inflammasome is essential for host-defense against cytosolic bacteria and DNA viruses , 2010, Nature Immunology.

[37]  S. Akira,et al.  Pattern Recognition Receptors and Inflammation , 2010, Cell.

[38]  Jing Yuan,et al.  Defective Circulating CD4+CD25+Foxp3+CD127low Regulatory T-cells in Patients with Chronic Heart Failure , 2010, Cellular Physiology and Biochemistry.

[39]  R. Kitsis,et al.  Cell death in the pathogenesis of heart disease: mechanisms and significance. , 2010, Annual review of physiology.

[40]  F. Gao,et al.  The Cytoprotective Effects of Tumor Necrosis Factor Are Conveyed Through Tumor Necrosis Factor Receptor–Associated Factor 2 in the Heart , 2010, Circulation. Heart failure.

[41]  D. Mann,et al.  Innate immunity in the adult mammalian heart: for whom the cell tolls. , 2010, Transactions of the American Clinical and Climatological Association.

[42]  Z. Radojicic,et al.  Relationship between RANKL and neuroendocrine activation in elderly males with heart failure , 2010, Endocrine.

[43]  P. Meier,et al.  A tangled web of ubiquitin chains: breaking news in TNF-R1 signaling. , 2009, Molecular cell.

[44]  W. Min,et al.  TNF Receptors Differentially Signal and Are Differentially Expressed and Regulated in the Human Heart , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[45]  E. Benarroch.  Autonomic-mediated immunomodulation and potential clinical relevance , 2009, Neurology.

[46]  M. Kleinewietfeld,et al.  Regulatory T Cells Ameliorate Angiotensin II–Induced Cardiac Damage , 2009, Circulation.

[47]  S. Girardin,et al.  Unleashing the therapeutic potential of NOD-like receptors , 2009, Nature Reviews Drug Discovery.

[48]  J. Fildes,et al.  The immune system and chronic heart failure: is the heart in control? , 2009, Journal of the American College of Cardiology.

[49]  G. Wang,et al.  Divergent Tumor Necrosis Factor Receptor-Related Remodeling Responses in Heart Failure: Role of Nuclear Factor-&kgr;B and Inflammatory Activation , 2009, Circulation.

[50]  I. Elenkov.  Neuroendocrine Effects on Immune System , 2009 .

[51]  Ruslan Medzhitov,et al.  Pattern recognition receptors and control of adaptive immunity , 2009, Immunological reviews.

[52]  W. Frishman,et al.  Toll-Like Receptors: New Therapeutic Targets for the Treatment of Atherosclerosis, Acute Coronary Syndromes, and Myocardial Failure , 2008, Cardiology in review.

[53]  R. Medzhitov.  Origin and physiological roles of inflammation , 2008, Nature.

[54]  Jeffery L. Carter,et al.  Sympathetic modulation of immunity: relevance to disease. , 2008, Cellular immunology.

[55]  G. Hansson,et al.  Innate immunity, macrophage activation, and atherosclerosis , 2007, Immunological reviews.

[56]  D. Nance,et al.  Autonomic innervation and regulation of the immune system (1987–2007) , 2007, Brain, Behavior, and Immunity.

[57]  G. Ertl,et al.  Mechanisms of Disease: Toll-like receptors in cardiovascular disease , 2007, Nature Clinical Practice Cardiovascular Medicine.

[58]  T. Ueland,et al.  Role of inflammation in the progression of heart failure , 2007, Current cardiology reports.

[59]  W. Maixner,et al.  β2 adrenergic receptor activation stimulates pro-inflammatory cytokine production in macrophages via PKA- and NF-κB-independent mechanisms , 2007 .

[60]  Patrick M Flood,et al.  Beta2 adrenergic receptor activation stimulates pro-inflammatory cytokine production in macrophages via PKA- and NF-kappaB-independent mechanisms. , 2007, Cellular signalling.

[61]  Polly Matzinger,et al.  Friendly and dangerous signals: is the tissue in control? , 2007, Nature Immunology.

[62]  W. Jones,et al.  NF-κB in cardiovascular disease , 2007, Cardiovascular Toxicology.

[63]  T. Rogers,et al.  Regulating the regulator: NF-kappaB signaling in heart. , 2006, Journal of molecular and cellular cardiology.

[64]  R. Oberbeck.  Catecholamines: physiological immunomodulators during health and illness. , 2006, Current medicinal chemistry.

[65]  Nicholas W. Kin,et al.  It takes nerve to tell T and B cells what to do , 2006, Journal of leukocyte biology.

[66]  W. Koch,et al.  Lymphocyte levels of GRK2 (betaARK1) mirror changes in the LVAD-supported failing human heart: lower GRK2 associated with improved beta-adrenergic signaling after mechanical unloading. , 2006, Journal of cardiac failure.

[67]  P. Nawroth,et al.  Linking stress to inflammation. , 2006, Anesthesiology clinics.

[68]  K. Verhoeckx,et al.  Beta-adrenergic receptor agonists induce the release of granulocyte chemotactic protein-2, oncostatin M, and vascular endothelial growth factor from macrophages. , 2006, International immunopharmacology.

[69]  P. Vandenabeele,et al.  TNFR1‐ and TNFR2‐mediated signaling pathways in human kidney are cell type‐specific and differentially contribute to renal injury , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[70]  M. Nishimura,et al.  Tissue-specific mRNA expression profiles of human toll-like receptors and related genes. , 2005, Biological & pharmaceutical bulletin.

[71]  M. Caron,et al.  G Protein-Coupled Receptor Kinase 2 in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis , 2005, The Journal of Immunology.

[72]  R. Sakalauskas,et al.  The Role of β2-Adrenergic Receptors in Inflammation and Allergy , 2005 .

[73]  R. Sakalauskas,et al.  The role of beta(2)-adrenergic receptors in inflammation and allergy. , 2005, Current drug targets. Inflammation and allergy.

[74]  S. Prabhu.  Cytokine-Induced Modulation of Cardiac Function , 2004, Circulation research.

[75]  I. Dixon,et al.  Excessive Tumor Necrosis Factor Activation After Infarction Contributes to Susceptibility of Myocardial Rupture and Left Ventricular Dysfunction , 2004, Circulation.

[76]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[77]  B. Chandrasekar,et al.  β-Adrenergic stimulation induces interleukin-18 expression via β2-AR, PI3K, Akt, IKK, and NF-κB , 2004 .

[78]  R. Kvetňanský,et al.  Repeated Stress‐Induced Stimulation of Catecholamine Response Is Not Followed by Altered Immune Cell Redistribution , 2004, Annals of the New York Academy of Sciences.

[79]  Paul M. Ridker,et al.  Inflammation as a Cardiovascular Risk Factor , 2004, Circulation.

[80]  S. Prabhu.  Nitric oxide protects against pathological ventricular remodeling: reconsideration of the role of NO in the failing heart. , 2004, Circulation research.

[81]  R. Surabhi,et al.  Activation of Intrinsic and Extrinsic Proapoptotic Signaling Pathways in Interleukin-18-mediated Human Cardiac Endothelial Cell Death* , 2004, Journal of Biological Chemistry.

[82]  J. McMurray,et al.  Targeted Anticytokine Therapy in Patients With Chronic Heart Failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL) , 2004, Circulation.

[83]  T. Levade,et al.  N-Acetylcysteine Prevents the Deleterious Effect of Tumor Necrosis Factor-&agr; on Calcium Transients and Contraction in Adult Rat Cardiomyocytes , 2004, Circulation.

[84]  D. Mann,et al.  Targeted Overexpression of Noncleavable and Secreted Forms of Tumor Necrosis Factor Provokes Disparate Cardiac Phenotypes , 2004, Circulation.

[85]  B. Chandrasekar,et al.  Beta-adrenergic stimulation induces interleukin-18 expression via beta2-AR, PI3K, Akt, IKK, and NF-kappaB. , 2004, Biochemical and biophysical research communications.

[86]  P. Karczewski,et al.  Protein phosphorylation in isolated trabeculae from nonfailing and failing human hearts , 2004, Molecular and Cellular Biochemistry.

[87]  Douglas L Mann,et al.  Stress-activated cytokines and the heart: from adaptation to maladaptation. , 2003, Annual review of physiology.

[88]  James E. Evans,et al.  Molecular identification of a danger signal that alerts the immune system to dying cells , 2003, Nature.

[89]  J. Balligand,et al.  Nitric Oxide and Cardiac Function: Ten Years After, and Continuing , 2003, Circulation research.

[90]  D. Mann,et al.  Targeted Overexpression of Transmembrane Tumor Necrosis Factor Provokes a Concentric Cardiac Hypertrophic Phenotype , 2003, Circulation.

[91]  E. Chung,et al.  Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-&agr;, in Patients With Moderate-to-Severe Heart Failure: Results of the Anti-TNF Therapy Against Congestive Heart failure (ATTACH) Trial , 2003, Circulation.

[92]  G. Ertl,et al.  Increased myocardial oxygen consumption by TNF-α is mediated by a sphingosine signaling pathway , 2003 .

[93]  W. Tang,et al.  Pathophysiology of congestive heart failure. , 2003, Reviews in cardiovascular medicine.

[94]  C. Semsarian,et al.  Hypertrophic cardiomyopathy: from gene defect to clinical disease , 2003, Cell Research.

[95]  G. Ertl,et al.  Increased myocardial oxygen consumption by TNF-alpha is mediated by a sphingosine signaling pathway. , 2003, American journal of physiology. Heart and circulatory physiology.

[96]  Douglas L Mann,et al.  Inflammatory mediators and the failing heart: past, present, and the foreseeable future. , 2002, Circulation research.

[97]  Ronald Glaser,et al.  Depression and immune function: central pathways to morbidity and mortality. , 2002, Journal of psychosomatic research.

[98]  R. Straub,et al.  Norepinephrine, the β-Adrenergic Receptor, and Immunity , 2002, Brain, Behavior, and Immunity.

[99]  R. Kolesnick.  The therapeutic potential of modulating the ceramide/sphingomyelin pathway. , 2002, The Journal of clinical investigation.

[100]  F. Pecker,et al.  Arachidonic acid mediates dual effect of TNF-alpha on Ca2+ transients and contraction of adult rat cardiomyocytes. , 2002, American journal of physiology. Cell physiology.

[101]  J. Kiecolt-Glaser,et al.  Psychoneuroimmunology: psychological influences on immune function and health. , 2002, Journal of consulting and clinical psychology.

[102]  D. Mazurais,et al.  Cell Type-specific Localization of Human Cardiac S1P Receptors , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[103]  P. Matzinger.  The Danger Model: A Renewed Sense of Self , 2002, Science.

[104]  S. Frøland,et al.  Increased gene expression of tumor necrosis factor superfamily ligands in peripheral blood mononuclear cells during chronic heart failure. , 2002, Cardiovascular research.

[105]  Robert J. Lefkowitz,et al.  Seven-transmembrane-spanning receptors and heart function , 2002, Nature.

[106]  L. Killar,et al.  Sphingosine Modulates Myocyte Electrophysiology, Induces Negative Inotropy, and Decreases Survival After Myocardial Ischemia , 2002, Journal of cardiovascular pharmacology.

[107]  R. Straub,et al.  Norepinephrine, the beta-adrenergic receptor, and immunity. , 2002, Brain, behavior, and immunity.

[108]  P. D. del Nido,et al.  Rapid Endotoxin-induced Alterations in Myocardial Calcium Handling: Obligatory Role of Cardiac TNF-&agr; , 2001, Anesthesiology.

[109]  J. Pepper,et al.  Quantitative Myocardial Cytokine Expression and Activation of the Apoptotic Pathway in Patients Who Require Left Ventricular Assist Devices , 2001, Circulation.

[110]  P. D. del Nido,et al.  Inhibition of tumor necrosis factor-alpha improves postischemic recovery of hypertrophied hearts. , 2001, Circulation.

[111]  I. Shiojima,et al.  Sphingosine 1-Phosphate Activates Akt, Nitric Oxide Production, and Chemotaxis through a GiProtein/Phosphoinositide 3-Kinase Pathway in Endothelial Cells* , 2001, The Journal of Biological Chemistry.

[112]  P. Libby,et al.  Inflammation and thrombosis: the clot thickens. , 2001, Circulation.

[113]  David L. Williams,et al.  Early activation of IKKβ during in vivo myocardial ischemia , 2001 .

[114]  J. Willerson,et al.  Prospects for cardiovascular research. , 2001, JAMA.

[115]  R. Kao,et al.  Early activation of IKKbeta during in vivo myocardial ischemia. , 2001, American journal of physiology. Heart and circulatory physiology.

[116]  G. Chrousos,et al.  The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system. , 2000, Pharmacological reviews.

[117]  W. Seeger,et al.  Endotoxin-Induced Myocardial Tumor Necrosis Factor-&agr; Synthesis Depresses Contractility of Isolated Rat Hearts: Evidence for a Role of Sphingosine and Cyclooxygenase-2–Derived Thromboxane Production , 2000, Circulation.

[118]  F. Clubb,et al.  Cardiac-Specific Overexpression of Tumor Necrosis Factor-&agr; Causes Oxidative Stress and Contractile Dysfunction in Mouse Diaphragm , 2000, Circulation.

[119]  R. Lefkowitz,et al.  Preservation of myocardial β-adrenergic receptor signaling delays the development of heart failure after myocardial infarction , 2000 .

[120]  G. Freeman,et al.  beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. , 2000, Circulation.

[121]  R. Lefkowitz,et al.  Catecholamines, Cardiac b-Adrenergic Receptors, and Heart Failure , 2000 .

[122]  G. Chrousos,et al.  Ligand-Activation of the Adenosine A2a Receptors Inhibits IL-12 Production by Human Monocytes , 2000, The Journal of Immunology.

[123]  R. Lefkowitz,et al.  Preservation of myocardial beta-adrenergic receptor signaling delays the development of heart failure after myocardial infarction. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[124]  R. Lefkowitz,et al.  Functional consequences of altering myocardial adrenergic receptor signaling. , 2000, Annual review of physiology.

[125]  R. Lefkowitz,et al.  Catecholamines, cardiac beta-adrenergic receptors, and heart failure. , 2000, Circulation.

[126]  A. Kavelaars,et al.  The importance of being receptive , 1999, Journal of Neuroimmunology.

[127]  O. Kohmoto,et al.  Cellular basis for the acute inhibitory effects of IL-6 and TNF- alpha on excitation-contraction coupling. , 1999, Journal of molecular and cellular cardiology.

[128]  A. Harken,et al.  Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function. , 1999, Critical care medicine.

[129]  G. Hotamisligil.  The role of TNFα and TNF receptors in obesity and insulin resistance , 1999 .

[130]  J. Bijlsma,et al.  Decreased expression and activity of G‐protein‐coupled receptor kinases in peripheral blood mononuclear cells of patients with rheumatoid arthritis , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[131]  G. Camussi,et al.  Role of nitric oxide and platelet-activating factor in cardiac alterations induced by tumor necrosis factor-α in the guinea-pig papillary muscle , 1999 .

[132]  G. Kojda,et al.  Regulation of basal myocardial function by NO. , 1999, Cardiovascular research.

[133]  J. Parrillo,et al.  Effects of epinephrine and amrinone on contractility and cyclic adenosine monophosphate generation of tumor necrosis factor alpha-exposed cardiac myocytes. , 1999, Critical care medicine.

[134]  R. Kao,et al.  Early activation of transcription factor NF-kappaB during ischemia in perfused rat heart. , 1999, The American journal of physiology.

[135]  R. Kao,et al.  Early activation of transcription factor NF-κB during ischemia in perfused rat heart. , 1999, American journal of physiology. Heart and circulatory physiology.

[136]  F. Pecker,et al.  Evidence for a beta2-adrenergic/arachidonic acid pathway in ventricular cardiomyocytes. Regulation by the beta1-adrenergic/camp pathway. , 1999, The Journal of biological chemistry.

[137]  N. Edmunds,et al.  Effects of tumour necrosis factor‐α on left ventricular function in the rat isolated perfused heart: possible mechanisms for a decline in cardiac function , 1999, British journal of pharmacology.

[138]  G. Hotamisligil.  The role of TNFalpha and TNF receptors in obesity and insulin resistance. , 1999, Journal of internal medicine.

[139]  G. Camussi,et al.  Role of nitric oxide and platelet-activating factor in cardiac alterations induced by tumor necrosis factor-alpha in the guinea-pig papillary muscle. , 1999, Cardiovascular research.

[140]  D. Mary,et al.  The role of beta 2-adrenergic vascular receptors in the peripheral vasodilation caused by 17 beta-estradiol in anesthetized pigs. , 1999, Life sciences.

[141]  S. Liu,et al.  Suppression of beta-adrenergic responsiveness of L-type Ca2+ current by IL-1beta in rat ventricular myocytes. , 1999, The American journal of physiology.

[142]  R. Kennedy,et al.  Suppression of β-adrenergic responsiveness of L-type Ca2+ current by IL-1β in rat ventricular myocytes. , 1999, American journal of physiology. Heart and circulatory physiology.

[143]  Anand Kumar,et al.  Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

[144]  J. McHowat,et al.  Stimulation of different phospholipase A2 isoforms by TNF-alpha and IL-1beta in adult rat ventricular myocytes. , 1998, The American journal of physiology.

[145]  J. McHowat,et al.  Stimulation of different phospholipase A2 isoforms by TNF-α and IL-1β in adult rat ventricular myocytes. , 1998, American journal of physiology. Heart and circulatory physiology.

[146]  C. Szabó,et al.  Proinflammatory cytokines depress cardiac efficiency by a nitric oxide-dependent mechanism. , 1998, American journal of physiology. Heart and circulatory physiology.

[147]  Robert J. Lefkowitz,et al.  G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.

[148]  N. Edmunds,et al.  Effects of tumour necrosis factor‐α on the coronary circulation of the rat isolated perfused heart: a potential role for thromboxane A2 and sphingosine , 1998, British journal of pharmacology.

[149]  Y. Hannun,et al.  Glutathione Regulation of Neutral Sphingomyelinase in Tumor Necrosis Factor-α-induced Cell Death* , 1998, The Journal of Biological Chemistry.

[150]  K. Madden,et al.  The role of the sympathetic nervous system in the modulation of immune responses. , 1998, Advances in pharmacology.

[151]  E. Sternberg,et al.  Neural‐Immune Interactions in Health and Disease , 2002, The Journal of clinical investigation.

[152]  E. Braunwald.  Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. , 1997, The New England journal of medicine.

[153]  K. Werdan,et al.  Tumor necrosis factor alpha (TNF alpha) is cardiodepressant in pathophysiologically relevant concentrations without inducing inducible nitric oxide-(NO)-synthase (iNOS) or triggering serious cytotoxicity. , 1997, Journal of molecular and cellular cardiology.

[154]  A. Koretsky,et al.  Dilated Cardiomyopathy in Transgenic Mice With Cardiac-Specific Overexpression of Tumor Necrosis Factor-α , 1997 .

[155]  B. S. Robinson,et al.  Activation of neutral sphingomyelinase in human neutrophils by polyunsaturated‘qc fatty acids , 1997, Immunology.

[156]  S. Liu,et al.  Involvement of ceramide in inhibitory effect of IL-1 beta on L-type Ca2+ current in adult rat ventricular myocytes. , 1997, The American journal of physiology.

[157]  G. Dorn,et al.  Sphingosine Mediates the Immediate Negative Inotropic Effects of Tumor Necrosis Factor-α in the Adult Mammalian Cardiac Myocyte* , 1997, The Journal of Biological Chemistry.

[158]  Nicole Nelson,et al.  A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells , 1997, Nature.

[159]  M. Irwin,et al.  Modulation of immune cell function by the autonomic nervous system. , 1997, Pharmacology & therapeutics.

[160]  D. Damron,et al.  Arachidonic acid enhances contraction and intracellular Ca2+ transients in individual rat ventricular myocytes. , 1997, The American journal of physiology.

[161]  S. Alper,et al.  Reinterpretation of the RACTK1 K+ channel. , 1997, The American journal of physiology.

[162]  B. Castner,et al.  A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. , 1997, Nature.

[163]  S. Felten,et al.  Noradrenergic and peptidergic innervation of lymphoid organs. , 1997, Chemical immunology.

[164]  J. Benovic,et al.  Differentially regulated expression of the G-protein-coupled receptor kinases, betaARK and GRK6, during myelomonocytic cell development in vitro. , 1996, Blood.

[165]  K. H. Kim,et al.  Effects of TNF-alpha on [Ca2+]i and contractility in isolated adult rabbit ventricular myocytes. , 1996, The American journal of physiology.

[166]  B. Bozkurt,et al.  Basic mechanisms in heart failure: the cytokine hypothesis. , 1996, Journal of cardiac failure.

[167]  D. Mann,et al.  Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human Heart , 1996 .

[168]  Hong-Bing Shu,et al.  TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways , 1996, Cell.

[169]  D. Mann,et al.  Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. , 1996, Circulation.

[170]  K. Madden,et al.  Sympathetic Nervous System‐Immune System Interactions in Young and Old Fischer 344 Rats , 1995, Annals of the New York Academy of Sciences.

[171]  George Kollias,et al.  The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor , 1995, Cell.

[172]  D. Mann,et al.  Expression and functional significance of tumor necrosis factor receptors in human myocardium. , 1995, Circulation.

[173]  R. Lefkowitz,et al.  Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. , 1995, Science.

[174]  K. Madden,et al.  Catecholamine influences and sympathetic neural modulation of immune responsiveness. , 1995, Annual review of pharmacology and toxicology.

[175]  K. Madden,et al.  Experimental basis for neural-immune interactions. , 1995, Physiological reviews.

[176]  A. Leaf,et al.  Effects of long-chain polyunsaturated fatty acids on the contraction of neonatal rat cardiac myocytes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[177]  A. Yao,et al.  Nitric oxide-mediated effects of interleukin-6 on [Ca2+]i and cell contraction in cultured chick ventricular myocytes. , 1994, Circulation research.

[178]  Y. Hannun,et al.  Identification of arachidonic acid as a mediator of sphingomyelin hydrolysis in response to tumor necrosis factor alpha. , 1994, The Journal of biological chemistry.

[179]  G. Jenkins,et al.  Modulation of cardiac sarcoplasmic reticulum ryanodine receptor by sphingosine. , 1994, Journal of molecular and cellular cardiology.

[180]  P. D. del Nido,et al.  Myocardial effects of interleukin-2. , 1994, Transplantation proceedings.

[181]  L. Vaca,et al.  Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. , 1993, The Journal of clinical investigation.

[182]  S. Felten,et al.  Noradrenergic and peptidergic innervation of secondary lymphoid organs: role in experimental rheumatoid arthritis. , 1992, European journal of clinical investigation.

[183]  Simon C Watkins,et al.  Negative inotropic effects of cytokines on the heart mediated by nitric oxide. , 1992, Science.

[184]  S. Felten,et al.  Noradrenergic and peptidergic innervation of lymphoid organs. , 1992, Chemical immunology.

[185]  E. Borda,et al.  Positive inotropic effect of interleukin-2. Role of phospholipases and protein kinase C. , 1991, International journal of immunopharmacology.

[186]  G. Schreiner,et al.  Mechanism of cytokine inhibition of beta-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes. Impairment of signal transduction. , 1990, Circulation research.

[187]  G. Schreiner,et al.  Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[188]  E. Borda,et al.  Stimulation of heart contractility by supernatants from lectin-activated lymphocytes. Role of IL-2. , 1989, International journal of immunopharmacology.

[189]  S. Hatfield,et al.  Beta-adrenergic agonists blocked the expression of IL-2 receptors on mitogen-stimulated lymphocytes and IL-2-dependent T cell lines. , 1988, Journal of immunology.

[190]  G. Ramadori,et al.  Interleukin 6, the third mediator of acute‐phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1 β and tumor necrosis factor‐α , 1988 .

[191]  G. Ramadori,et al.  Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1 beta and tumor necrosis factor-alpha. , 1988, European journal of immunology.